Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Salmon

Showing results (671-680 of 694) with videos related to

Pageof 70
Sort By:
Alzheimer'S Research & Therapy|May 2, 2025
Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's diseaseYuqi Qiu, Diane M Jacobs, Karen Messer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 22, 2021
Normative data for the Brief Spanish-English Verbal Learning Test for representative and diverse Hispanics/Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)Jordana Breton, Ariana M Stickel, Wassim Tarraf, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2013
Improving dementia care: the role of screening and detection of cognitive impairmentSoo Borson, Lori Frank, Peter J Bayley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 14, 2014
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's diseaseMichael S Rafii, Tiffany L Baumann, Roy A E Bakay, et al.
Archives of Neurology|October 13, 2010
Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phaseJing He, Ana-Maria Iosif, Dong Young Lee, et al.
Nature Medicine|April 27, 2005
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer diseaseMark H Tuszynski, Leon Thal, Mary Pay, et al.
International Journal of Aging & Human Development|August 16, 2024
Overcoming Barriers to Latino Participation in Alzheimer's Disease ResearchKevyn A Ramirez, Christina Gigliotti, Emily A Little, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's DiseaseHoward H Feldman, Karen Messer, Yuqi Qiu, et al.
Plos One|May 29, 2024
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)Howard H Feldman, José A Luchsinger, Gabriel C Léger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2025
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)L Malorni, S Tyekucheva, A Gombos, et al.
Pageof 70

Showing results (671-680 of 694) with videos related to

Sort By:
Pageof 70
Alzheimer'S Research & Therapy|May 2, 2025
Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's diseaseYuqi Qiu, Diane M Jacobs, Karen Messer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 22, 2021
Normative data for the Brief Spanish-English Verbal Learning Test for representative and diverse Hispanics/Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)Jordana Breton, Ariana M Stickel, Wassim Tarraf, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2013
Improving dementia care: the role of screening and detection of cognitive impairmentSoo Borson, Lori Frank, Peter J Bayley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 14, 2014
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's diseaseMichael S Rafii, Tiffany L Baumann, Roy A E Bakay, et al.
Archives of Neurology|October 13, 2010
Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phaseJing He, Ana-Maria Iosif, Dong Young Lee, et al.
Nature Medicine|April 27, 2005
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer diseaseMark H Tuszynski, Leon Thal, Mary Pay, et al.
International Journal of Aging & Human Development|August 16, 2024
Overcoming Barriers to Latino Participation in Alzheimer's Disease ResearchKevyn A Ramirez, Christina Gigliotti, Emily A Little, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's DiseaseHoward H Feldman, Karen Messer, Yuqi Qiu, et al.
Plos One|May 29, 2024
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam)Howard H Feldman, José A Luchsinger, Gabriel C Léger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2025
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)L Malorni, S Tyekucheva, A Gombos, et al.
Pageof 70